// App-Quantinova.ai

SUN-0156 : Immunohistochemical Markers As Potential Predictors of Malignancy in Gonadal Dysgenesis

Researchers

Presenter

  • Bonnie Marie McCann-Crosby

Principal Investigators

  • Sheila Kaye Gunn

  • M. John Hicks

  • Lefkothea P Karaviti

Medical Centers

  • Baylor College of Medicine/Texas Children's Hospital, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Turner syndrome

  • Germ cell tumor

  • 46,XY sex reversal 1

Biomarkers

  • Alpha-fetoprotein

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase

Drug/Treatment

  • Alkaline phosphatase

  • Alfa-fetoprotein

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved